Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-329.63	-2296.14	-534.44
Graham Fair Price	65.37	5.95	3.60
PEG	-90.99	< 0.005	-0.07
Price/Book	7.99	0.29	0.27
Price/Cash Flow	149.73	-0.60	0.24
Prices/Earnings	-56.69	2.34	5.40
Price/Sales	36.46	4.15	3.04
Price/FCF	149.73	-0.60	0.24
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	101.66	0.98	0.48
Operating Margin	358.35	0.57	0.12
ROA	156.20	< 0.005	< 0.005
ROE	0.01	0.03	149.37
ROIC	< 0.005	< 0.005	133.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	0.10	6.59
Dividends QOQ	-0.16	-0.66	-303.21
EBIT QOQ	-0.66	2.75	318.30
EPS QOQ	-0.73	3.50	380.41
FCF QOQ	10.13	-1.45	-85.71
Revenue QOQ	-0.20	-0.18	8.40
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	618.84	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.68	0.70	2.12
Quick Ratio	5.54	17.37	213.74
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.84	7.16	4.72
Cash	3.52	5.42	53.85
Capex	-0.14	-0.07	51.85
Free Cash Flow	7.55	-3.42	-54.72
Revenue	0.60	0.50	-17.12
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.55	17.37	580.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-397.39	-1810.55	-355.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating